申请人:ENVOY THERAPEUTICS, INC.
公开号:US20150291624A1
公开(公告)日:2015-10-15
The present invention provides compounds of the formula:
that are 5HT3 receptor antagonists and are therefore useful for the treatment of diseases treatable by inhibition of 5HT3 receptor such as emesis, pain, drug addiction, neurodegenerative and psychiatric disorders, and GI disorders. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
本发明提供了以下公式的化合物:它们是5HT3受体拮抗剂,因此可用于治疗可通过抑制5HT3受体治疗的疾病,如恶心、疼痛、药物成瘾、神经退行性和精神障碍以及消化系统疾病。还提供了含有这些化合物的制药组合物和制备这些化合物的过程。